Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis
Patients with hepatitis C virus (HCV) often have elevated serum markers and histologic features of autoimmune hepatitis (AIH). We evaluated an HCV‐positive (HCV+) study group that had elevated serum markers of AIH before starting direct‐acting antiviral (DAA) therapy (n = 21) and compared them to an...
Main Authors: | Camila C. Simoes, Omar A. Saldarriaga, Netanya S. Utay, Ashley E. Stueck, Sheharyar K. Merwat, Shehzad N. Merwat, Thomas D. Schiano, Maria Isabel Fiel, Heather L. Stevenson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1388 |
Similar Items
-
Restarting elective endoscopy safely amidst an evolving pandemic and the impact of patient perception
by: Christopher Nguyen, et al.
Published: (2021-09-01) -
Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome
by: Omar A. Saldarriaga, et al.
Published: (2021-07-01) -
Liver histopathological diagnosis of autoimmune hepatitis
by: MIAO Qi
Published: (2020-04-01) -
Liver transplant recipient with respiratory failure due to pulmonary fibrosis related to telomere disease requiring lung transplantation
by: Mandeep Singh, et al.
Published: (2021-01-01) -
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.
by: Elisabetta Loggi, et al.
Published: (2017-01-01)